$8.91
-0.27-2.94%
At Close: -
$8.91
00.00%
After Hours: Sep 20, 4:03 PM EDT
15 minutes delayed
EyePoint Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of EyePoint Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.58 | $-0.52 | -11.5 % |
Mar 2024 | 2024-05-08 | $-0.55 | $-0.42 | -30.9 % |
Dec 2023 | 2024-03-07 | $-0.33 | $-0.49 | 32.6 % |
Sep 2023 | 2023-11-01 | $-0.33 | $-0.51 | 35.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $9.48M | $9.59M | -1.18 % |
Mar 2024 | 2024-05-08 | $11.68M | $9.92M | 17.8 % |
Dec 2023 | 2024-03-07 | $14.03M | $8.90M | 57.6 % |
Sep 2023 | 2023-11-01 | $15.20M | $7.52M | 102.2 % |
EyePoint Pharmaceuticals (EYPT) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.58, which missed the estimate of $-0.52.
The Actual Revenue was $9.5M, which missed the estimate of $9.6M.
Browse earnings estimates, EPS, and revenue on all stocks.